Literature DB >> 1988230

Evidence that X-linked severe combined immunodeficiency is not a differentiation defect of T lymphocytes.

J Goodship1, S Malcolm, R J Levinsky.   

Abstract

In order to gain information about the nature of the defect in X-linked severe combined immunodeficiency (XSCID), we investigated gene expression in different lymphoid and haematopoietic cells of female carriers by looking for non-random X chromosome usage. We have shown non-random X chromosome usage in T lymphocyte enriched (E+) fraction in all carriers. E- cells and monocytes showed non-random X chromosome usage in three carriers tested. In the B cell series one carrier showed non-random inactivation in all EBV lines tested (10) and the same X chromosome was shown to be active in all cells. In other carriers there was a preference for use of the normal X chromosome but some B cell lines used the mutant X as well as the normal X. Similar results were found with granulocytes. In two female carriers DNA made directly from whole blood showed a non-random pattern of X chromosome usage. In fibroblast cultures from two female carriers more cells had the normal gene on the active X chromosome than had the defective gene on the active X chromosome. Within families there was heterogeneous expression of the gene. The gene that is defective in XSCID is expressed in all the cell types studied and, therefore, is not a T lymphocyte differentiation gene. The results are consistent with the gene being in a metabolic pathway as in certain autosomal recessive forms of SCID i.e. adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1988230      PMCID: PMC1535476          DOI: 10.1111/j.1365-2249.1991.tb05579.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  8 in total

1.  Selective defect of precursor T cells associated with apparently normal B lymphocytes in severe combined immunodeficiency disease.

Authors:  C Griscelli; A Durandy; J L Virelizier; J J Ballet; F Daguillard
Journal:  J Pediatr       Date:  1978-09       Impact factor: 4.406

2.  Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency.

Authors:  M E Conley; A Lavoie; C Briggs; P Brown; C Guerra; J M Puck
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

3.  Use of X chromosome inactivation analysis to establish carrier status for X-linked severe combined immunodeficiency.

Authors:  J Goodship; S Malcolm; Y L Lau; M E Pembrey; R J Levinsky
Journal:  Lancet       Date:  1988-04-02       Impact factor: 79.321

4.  Carrier detection in X-linked severe combined immunodeficiency based on patterns of X chromosome inactivation.

Authors:  J M Puck; R L Nussbaum; M E Conley
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

5.  Clonal analysis using recombinant DNA probes from the X-chromosome.

Authors:  B Vogelstein; E R Fearon; S R Hamilton; A C Preisinger; H F Willard; A M Michelson; A D Riggs; S H Orkin
Journal:  Cancer Res       Date:  1987-09-15       Impact factor: 12.701

6.  Clonal evolution in human lymphoblast cultures.

Authors:  B R Migeon; J Axelman; G Stetten
Journal:  Am J Hum Genet       Date:  1988-05       Impact factor: 11.025

7.  X-linked severe combined immunodeficiency: localization within the region Xq13.1-q21.1 by linkage and deletion analysis.

Authors:  J M Puck; R L Nussbaum; D L Smead; M E Conley
Journal:  Am J Hum Genet       Date:  1989-05       Impact factor: 11.025

8.  Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X.

Authors:  W Reith; S Satola; C H Sanchez; I Amaldi; B Lisowska-Grospierre; C Griscelli; M R Hadam; B Mach
Journal:  Cell       Date:  1988-06-17       Impact factor: 41.582

  8 in total
  2 in total

1.  Differential methylation at the 5' and the 3' CCGG sites flanking the X chromosomal hypervariable DXS255 locus.

Authors:  R W Hendriks; M E Kraakman; R G Mensink; R K Schuurman
Journal:  Hum Genet       Date:  1991-11       Impact factor: 4.132

Review 2.  The molecular basis of X-linked immunodeficiency disease.

Authors:  C Kinnon; R Levinsky
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.